The theme: Telehealth, digital-first care and the software running clinical trials, prescribing and imaging. Filed under Health Information Services, Healthcare Plans and Diagnostics — united by delivering or administering care through software rather than a building.
How this ranking works
Standard classifications describe what a company files as, not what it's a bet on. This is a curated list of the Digital Health names in our US universe: the pure-plays, plus the larger companies for which Digital Health is a real, reported driver rather than a passing mention. Each carries the same 0–100 quality-growth score used everywhere on the site (how it's built), and re-scores every trading day.
The 9 members report under 4 different industries, which is exactly why no standard sector view groups them:
Health Information Services4
Healthcare Plans3
Diagnostics & Research1
Drug Manufacturers - Specialty & Generic1
What kind of businesses these are
Average pillar scores across the 9 scored members, against every stock the model scores:
Pillar
Digital Health
Market
Read
Quality
61.8
56.5
5.3 above
Growth
78.4
58.8
19.6 above
Value
63.1
44.8
18.3 above
Pillars run 0–100 against sector peers. A low Value reading means the group is expensive relative to what it earns, not that the businesses are weak — for an early-stage theme that is the normal shape.
Scores across the group run from DOCS at 84.2 down to HIMS at 39.7, with a median of 65.1. A theme is a thesis, not a quality filter — membership says a company is exposed to Digital Health, and the score says what the model makes of the business.
Where analysts are moving on Digital Health
Across the 8 Digital Health names with a reading, the median forward earnings estimate is roughly unchanged — +0.9% over 90 days, ahead of the market (+0.3%). 4 of 8 are being revised up, 3 down.
Forward earnings estimates implied by price ÷ forward P/E, both captured at the same moment each trading day since June 2026, so a moving share price does not move these figures — only a changed forecast does. 8 of 9 members carry a reading; the rest have no forward P/E to imply one from, which is normal for loss-makers. Estimate direction is not part of the Bull Rankings score. Biggest movers across the market →
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.